In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
Did you know that your browser is out of date? To get the best experience using our website we recommend that you upgrade to a newer version. Learn more.
This content in this section refers to the previous congress. It is only here for reference purposes.

Partner Overview

ESC Asia with APSC & AFC

 Satellite Symposia

Get the latest news on industry innovations in the field and interact with experts on cutting-edge sessions regarding the latest science in a clinical Asian perspective:Industry partners will feature in our daily programme during dedicated Satellite Symposia slots:


Timeslot (SGT)

Session Title

Organised by

Friday 4 December (Day 1)


Challenging Paradigms and Changing the Course of Chronic Kidney Disease The Era of SGLT2i



Atrial Fibrillation Management: from Clinical Evidence to Real World Practice

Boehringer Ingelheim


Single-pill Combinations in the Management of Hypertension: Evidence from
New Guidelines, Practical Benefits for Both Physicians and Patients


Saturday 5 December (Day 2)


What Have We Learned from SGLT-2 Inhibitors in Heart Failure?

Boehringer Ingelheim


Paradigm Shifts in HFrEF Management: SGLT2-Inhibitors



Ischaemic Disease: the Importance of Choosing the Right Time and the Right
Therapeutic Approach